| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 42.5K | $1.19M | $27.95 | Sep 3, 2024 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 5.23K | May 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | Sep 3, 2024 | 1 | -$1.29M | 4 | Sep 4, 2024 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |